{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:17:45Z","timestamp":1791022665543,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126549","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:25:52Z","timestamp":1733120752000},"page":"126549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications"],"prefix":"10.1016","volume":"44","author":[{"given":"Natalia","family":"Olivero-Deibe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel N.","family":"Frigini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihu\u00e9n","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Benech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Arbiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126549_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2234430","article-title":"Mechanisms of circovirus immunosuppression and pathogenesis with a focus on porcine circovirus 2: a review","volume":"43","author":"Feh\u00e9r","year":"2023","journal-title":"Vet Q"},{"key":"10.1016\/j.vaccine.2024.126549_bb0010","first-page":"11","article-title":"Revisiting porcine circovirus infection: recent insights and its significance in the piggery sector","author":"Maity","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126549_bb0015","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1002\/jmv.27080","article-title":"Cyclovirus detection in Chilean adults with and without community-acquired pneumonia","volume":"93","author":"Prades","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0020","first-page":"14","article-title":"Advances in crosstalk between porcine circoviruses and host","author":"Niu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126549_bb0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1354\/vp.41-6-624","article-title":"Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with mycoplasma hyopneumoniae and porcine circovirus type 2","volume":"41","author":"Opriessnig","year":"2004","journal-title":"Vet Pathol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2024.126549_bb0030","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1099\/0022-1317-79-9-2171","article-title":"Characterization of novel circovirus DNAs associated with wasting syndromes in pigs","volume":"79","author":"Meehan","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1079\/AHR2005106","article-title":"Porcine circovirus diseases","volume":"6","author":"Segal\u00e9s","year":"2005","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2024.126549_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01314286","article-title":"Studies on epidemiology and pathogenicity of porcine circovirus","volume":"91","author":"Tischer","year":"1986","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01310498","article-title":"Comparison of three animal viruses with circular single-stranded DNA genomes","volume":"117","author":"Todd","year":"1991","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0050","first-page":"93","article-title":"Conformational changes and nuclear entry of porcine circovirus without disassembly","author":"Wang","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0055","first-page":"13","article-title":"Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology","author":"Franzo","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2024.126549_bb0060","first-page":"93","article-title":"Porcine circovirus 2 uses a multitude of weak binding sites to interact with Heparan sulfate, and the interactions do not follow the symmetry of the capsid","author":"Dhindwal","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0065","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.str.2015.12.006","article-title":"2.9 \u00c5 resolution Cryo-EM 3D reconstruction of close-packed virus particles","volume":"24","author":"Liu","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2024.126549_bb0075","first-page":"15","article-title":"Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope","author":"Mo","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.126549_bb0080","first-page":"12","article-title":"First identification and phylogenetic analysis of porcine circovirus type 4 in Fur animals in Hebei, China","author":"Wang","year":"2022","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.vaccine.2024.126549_bb0085","first-page":"14","article-title":"The first dog-origin porcine circovirus type 4 complete genomic sequence have high homology with that of pig-derived strains","author":"Xu","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0090","first-page":"14","article-title":"Best practice and future challenges for vaccination against porcine circovirus type 2","author":"Segal\u00e9s","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.126549_bb0095","first-page":"286","article-title":"Porcine circoviruses: current status, knowledge gaps and challenges","author":"Opriessnig","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.126549_bb0100","first-page":"7","article-title":"A dual swine challenge with porcine circovirus type 2 (PCV2) and mycoplasma Hyopneumoniae used to compare a combination of mixable monovalent PCV2 and monovalent M. Hyopneumoniae vaccines with a ready-to-use PCV2 and M. Hyopneumoniae bivalent vaccine","author":"Yang","year":"2020","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126549_bb0105","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107 Suppl","author":"Vicente","year":"2011","journal-title":"J Invertebr Pathol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rvsc.2011.10.018","article-title":"Virus-like particles: potential veterinary vaccine immunogens","volume":"93","author":"Liu","year":"2012","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126549_bb0115","first-page":"55","article-title":"Exploiting virus-like particles as innovative vaccines against emerging viral infections","author":"Jeong","year":"2017","journal-title":"J Microbiol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0120","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1099\/0022-1317-81-9-2281","article-title":"Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein","volume":"81","author":"Nawagitgul","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106630","article-title":"Optimized production of full-length PCV2d virus-like particles in Escherichia coli: a cost-effective and high-yield approach for potential vaccine antigen development","volume":"190","author":"Zhang","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2024.126549_bb0130","first-page":"11","article-title":"A field efficacy trial of recombinant porcine circovirus type 2d vaccine in three herds","author":"Ju","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126549_bb0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1354\/vp.40-5-521","article-title":"Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus","volume":"40","author":"Opriessnig","year":"2003","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0140","first-page":"11","article-title":"Selection and evaluation of porcine circovirus (PCV) 2d vaccine strains to protect against currently prevalent PCV2","author":"Ju","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126549_bb0145","first-page":"537","article-title":"Structural characterization of the PCV2d virus-like particle at 3.3\u00a0\u00c5 resolution reveals differences to PCV2a and PCV2b capsids, a tetranucleotide, and an N-terminus near the icosahedral 3-fold axes","author":"Khayat","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.126549_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coviro.2018.08.007","volume":"31","author":"Hadden","year":"2018","journal-title":"All-atom virus simulations Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0155","first-page":"48","article-title":"Fighting viruses with computers, right now","author":"Machado","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2023.107985","article-title":"The SIRAH force field: a suite for simulations of complex biological systems at the coarse-grained and multiscale levels","volume":"215","author":"Klein","year":"2023","journal-title":"J Struct Biol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0165","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.vaccine.2024.126549_bb0170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/acs.jpclett.6b02759","article-title":"All-atom molecular dynamics simulations of entire virus capsid reveal the role of ion distribution in Capsid\u2019s stability","volume":"8","author":"Tarasova","year":"2017","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.vaccine.2024.126549_bb0175","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jcc.21224","article-title":"PACKMOL: a package for building initial configurations for molecular dynamics simulations","volume":"30","author":"Mart\u00ednez","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.vaccine.2024.126549_bb0180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cplett.2003.10.013","article-title":"Self-guided Langevin dynamics simulation method","volume":"381","author":"Wu","year":"2003","journal-title":"Chem Phys Lett"},{"key":"10.1016\/j.vaccine.2024.126549_bb0185","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1998","journal-title":"J Chem Phys"},{"key":"10.1016\/j.vaccine.2024.126549_bb0190","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2--a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2024.126549_bb0200","first-page":"94","article-title":"The carboxyl terminus of the porcine circovirus type 2 capsid protein is critical to virus-like particle assembly, cell entry, and propagation","author":"Zhan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcpa.2010.07.001","article-title":"Porcine circovirus type 2 morphogenesis in a clone derived from the l35 lymphoblastoid cell line","volume":"144","author":"Rodr\u00edguez-Cari\u00f1o","year":"2011","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2024.126549_bb0210","first-page":"10","article-title":"Breed differences in PCV2 uptake and disintegration in porcine monocytes","author":"Wei","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126549_bb0215","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/21505594.2020.1832366","article-title":"Nucleolar protein NPM1 is essential for circovirus replication by binding to viral capsid","volume":"11","author":"Zhou","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2024.126549_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2019.11.008","article-title":"Early antibody responses map to non-protective, PCV2 capsid protein epitopes","volume":"540","author":"Ilha","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.126549_bb0225","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1021\/acs.jctc.7b00659","article-title":"MD simulations of virus-like particles with supra CG solvation affordable to desktop computers","volume":"13","author":"Machado","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.vaccine.2024.126549_bb0230","first-page":"7","article-title":"Structural insights into the assembly and regulation of distinct viral capsid complexes","author":"Sarker","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126549_bb0235","doi-asserted-by":"crossref","DOI":"10.3201\/eid2905.221485","article-title":"Unknown circovirus in immunosuppressed patient with hepatitis, France, 2022","volume":"29","author":"Rodriguez","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126549_bb0240","first-page":"30","article-title":"Circovirus hepatitis in immunocompromised patient, Switzerland","author":"Hamelin","year":"2024","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:47:45Z","timestamp":1735674465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"alternative-id":["S0264410X24012313"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126549","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126549"}}